WebSerious hypersensitivity reactions, including anaphylaxis, during or soon after administration of CINVANTI have occurred. Symptoms including dyspnea, eye swelling, flushing, pruritus, and wheezing have been reported. If hypersensitivity reactions occur, discontinue CINVANTI. WebMar 10, 2024 · Use of CINVANTI with strong CYP3A4 inducers (e.g., rifampin) may result in a reduction in aprepitant plasma concentrations and decreased efficacy of CINVANTI. Hypersensitivity Reactions Serious hypersensitivity reactions, including anaphylaxis, during or soon after administration of CINVANTI have occurred.
Heron Connect® FAQs for CINVANTI® (aprepitant) injectable …
WebSerious hypersensitivity reactions, including anaphylaxis, during or soon after administration of CINVANTI have occurred. Symptoms including dyspnea, eye swelling, flushing, pruritus, and wheezing have been reported. If hypersensitivity reactions occur, discontinue CINVANTI. motorcycle technology center york pa
Reference ID: 4179305 - Food and Drug Administration
WebMay 2, 2024 · The use of CINVANTI® as an alternative to IV EMEND® can reduce the need for rescue therapy and may lower the incidence of infusion site reactions. In addition, it was discovered that patients with active diabetes and those receiving one or more vesicants are at a substantially higher risk of infusion site reactions. WebJun 7, 2024 · Adverse reactions observed in these adequate and well-controlled studies are described below. Safety Of CINVANTI A total of 200 healthy subjects received a single 130 mg dose of CINVANTI as a 30-minute infusion. Adverse reactions reported in at least 2% of subjects were headache (3%) and fatigue (2%). WebSerious hypersensitivity reactions, including anaphylaxis, during or soon after administration of CINVANTI have occurred. Symptoms including dyspnea, eye swelling, flushing, pruritus, and wheezing have been reported. If hypersensitivity reactions occur, discontinue CINVANTI. motorcycle technology center